Invitron Limited

Invitron is developing a portable diagnostic device that utilises high-sensitivity chemiluminescence detection to provide accurate point of care tests, using tiny blood samples that can be obtained by fingerstick.

Invitron is developing a portable device that will perform rapid, accurate diagnostic tests using tiny blood samples that can be obtained by fingerstick. The device is based on a next generation chemiluminescence technology that will deliver laboratory quality results at the point of care. In this project we are developing a test that measures the biomarker cardiac troponin, a blood protein which is elevated in patients who have suffered a heart attack. Test results will enable a diagnosis to be made rapidly in the emergency room or even an ambulance, thus eliminating delays while blood samples are sent to a laboratory for analysis. This will in turn facilitate earlier transfer of patients who have suffered a heart attack to coronary care, while also enabling earlier discharge of those who have not. Patients will benefit from this early diagnosis which will also reduce pressure on emergency departments by accelerating turnaround time.